Publication | Open Access

Nanostructured lipid carriers for oral delivery of silymarin: Improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome model

Lipid PreparationNanomedicineEngineeringMetabolic Syndrome ModelMedicineDiabetesType 2Pharmaceutical NanotechnologyNanostructured Lipid CarriersNano-drug DeliveryBiomedical EngineeringDrug Delivery SystemPharmacology